Defining Pharmacological Targets by Analysis of Virus-Host Protein Interactions

Adv Protein Chem Struct Biol. 2018:111:223-242. doi: 10.1016/bs.apcsb.2017.11.001. Epub 2017 Dec 18.

Abstract

Viruses are obligate parasites that depend on cellular factors for replication. Pharmacological inhibition of essential viral proteins, mostly enzymes, is an effective therapeutic alternative in the absence of effective vaccines. However, this strategy commonly encounters drug resistance mechanisms that allow these pathogens to evade control. Due to the dependency on host factors for viral replication, pharmacological disruption of the host-pathogen protein-protein interactions (PPIs) is an important therapeutic alternative to block viral replication. In this review we discuss salient aspects of PPIs implicated in viral replication and advances in the development of small molecules that inhibit viral replication through antagonism of these interactions.

Keywords: Cellular cofactors; Protein complexes; Protein–protein interaction; Small organic molecules; Viral replication; Viruses; Virus–host interactome; Virus–host protein interactions.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Host Microbial Interactions / drug effects*
  • Humans
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*
  • Viral Proteins / chemistry
  • Viral Proteins / drug effects*
  • Viruses / chemistry
  • Viruses / drug effects*

Substances

  • Antiviral Agents
  • Small Molecule Libraries
  • Viral Proteins